Jump to content

New vaccine trial begins in the US

Support Team

Recommended Posts

A new phase II trial for pancreatic cancer looking at sequential treatment with two cancer vaccines: Aduro's CRS-207 and GVAX Pancreas Cancer Vaccine (GVAX Pancreas)has begun recruting in the US.

For more information see http://www.fiercebiotech.com/press-releases/aduro-biotech-announces-first-patient-treated-phase-2-pancreatic-cancer-tri-0?utm_medium=nl&utm_source=internal


Link to comment
Share on other sites

  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. By using our forums you agree to our Terms of Use and Privacy Policy.